In this installment of Quva Talks Quality, Chief Quality Officer David Short explains what health systems should expect from a 503B outsourcing partner as regulatory standards continue to evolve. He walks through how Quva builds quality into every stage of manufacturing - from validated processes and environmental monitoring to ongoing process verification and stability programs - and why those systems matter for hospital pharmacy teams trying to reduce supply uncertainty.
What Strong Quality Systems Mean for Hospitals
Short argues that quality isn't just a compliance checkbox - it's what lets pharmacy teams focus on patient care instead of worrying about product reliability. As 503B regulatory expectations shift, he says hospitals need partners who are strengthening their systems ahead of tomorrow's standards, not just meeting today's. Learn more about how Quva's FDA-registered 503B outsourcing model helps health systems build that confidence into their medication supply.
How to Evaluate a 503B Outsourcing Partner
Rather than relying on brochures or sales presentations, Short recommends pharmacy leaders visit the facility, ask direct questions, and observe the culture firsthand. He suggests one question in particular reveals more than any audit report: "How does your work protect the patient?". For the full list of questions to ask, download Quva's 503B Outsourcing Facility cGMP Checklist.